Who Owns Nasus Pharma Stock?
NYSE: NSRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 9, 10:00 AM ET
Ownership breakdown
- Held by institutions
- 18.36%
- Held by insiders
- 49.15%
- Institutional holders
- 10
- Institutions 18.4%
- Insiders 49.2%
- Public and other 32.5%
Who owns Nasus Pharma stock?
Institutional investors own about 18.4% of Nasus Pharma's shares, spread across 10 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 49.15% of NSRX.
The largest institutional holders are Balyasny Asset Management LP (7.67%), Cable Car Capital, LP (5.26%) and Velan Capital Investment Management LP (3.07%). Together, the top 10 institutions control 18.4% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their NSRX positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of NSRX
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Balyasny Asset Management LP | 898.47K | 7.67% | 0.0% |
| Cable Car Capital, LP | 616.08K | 5.26% | +2.3% |
| Velan Capital Investment Management LP | 359.39K | 3.07% | 0.0% |
| Hudson Bay Capital Management Lp | 134.77K | 1.15% | 0.0% |
| Bleichroeder LP | 89.85K | 0.77% | 0.0% |
| Citadel Advisors Llc | 22.00K | 0.19% | +100.0% |
| Xtx Topco Ltd | 16.64K | 0.14% | +100.0% |
| Renaissance Technologies, LLC | 12.20K | 0.10% | +100.0% |
| Morgan Stanley | 1.00K | 0.01% | -50.0% |
| Caitong International Asset Management Co., Ltd | 4 | 0.00% | +100.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Frequently asked questions
Who is the largest shareholder of Nasus Pharma?
Balyasny Asset Management LP is the largest institutional shareholder of NSRX, owning 7.67% of shares outstanding (898.47K shares) as of its latest 13F filing.
What percentage of Nasus Pharma is owned by institutions?
Institutions own about 18.4% of NSRX shares and 36.1% of the public float.
How much of Nasus Pharma do insiders own?
Insiders, such as officers and directors, own about 49.15% of NSRX shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.